KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1168 |
|---|---|
| Product Name | Anti-Human CD49e Recombinant Antibody |
| Molecular Name | Volociximab |
| Alias | Anti-CD49e Recombinant Antibody, Research Grade Volociximab |
| CAS Number | 558480-40-3 |
| Target | CD49e[Homo sapiens] |
| Isotype | IgG4 |
| Clonity | Monoclonal |
| Host | Mouse |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | ELISA, IHC |
| Buffer | PBS, pH7.5 |
| Background | Volociximab (also known as M200) is a chimeric monoclonal antibody jointly developed by PDL BioPharma and Biogen Idec for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of α5β1 integrin. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
